Closing the C-UAS Rules of Engagement (ROE) Gap, we established a critical reality: While Counter-Uncrewed Aircraft Systems ...

Zumba reports that becoming a group fitness instructor allows you to pursue fitness passions while helping others, with ...

Campbell Wright is a New Zealander to his core. But he competes for the U.S. and is the country's best hope to end a major Olympic drought.

MIT researchers developed a method that generates more accurate uncertainty measures for certain types of estimation. This could help improve the reliability of data analyses in areas like economics, ...

With less than 150 days left for the board exams, students are advised to start solving PYQs and sample papers. Here's a complete 2022 Business Studies question paper to help you strengthen exam ...

Sign up for essential news for the Fort Worth area. Delivered to your inbox — completely free. Cynthia Gonzalez left her Arlington home on Sept. 16, 1991 and wasn ...

Funding round was led by Yosemite, with participation from new investors Abingworth, Ally Bridge Group, B Capital, Balyasny Asset Management, Merck & Co., SymBiosis, and all existing investors SAN ...

Cynthia Gonzalez was killed in September 1991. More than 34 years later, students at UT Arlington have provided a break in the case that led to the arrest of 63-year-old Janie Perkins. Cynthia ...

SAN DIEGO--(BUSINESS WIRE)--Solve Therapeutics, a clinical-stage biotechnology company developing best-in-class antibody-drug conjugates (ADCs) for solid tumor malignancies, today announced it has ...

A San Diego biotech has set out to solve the formula for best-in-class antibody-drug conjugates, raising $120 million with support from Big Pharma Merck & Co. to fuel its efforts. Solve Therapeutics’ ...

Solve Therapeutics, a clinical-stage biotechnology company developing best-in-class antibody-drug conjugates (ADCs) for solid tumor malignancies, today announced it has raised $120 million in an ...

Funding round was led by Yosemite, with participation from new investors Abingworth, Ally Bridge Group, B Capital, Balyasny Asset Management, Merck & Co., SymBiosis, and all existing investors Solve ...